166 studies found for:    "thrombotic thrombocytopenic purpura" OR "Purpura, Thrombocytopenic"
Show Display Options
Rank Status Study
21 Completed An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Immune Thrombocytopenic Purpura
Intervention:
22 Completed
Has Results
Clinical Evaluation of SB-497115-GR in Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Chronic Idiopathic Thrombocytopenic Purpura;   Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: SB-497115-GR 12.5mg;   Drug: SB-497115-GR 25mg;   Drug: SB-497115-GR 12.5mg matching placebo;   Drug: SB-497115-GR 50 mg
23 Not yet recruiting Early Predictive Factors of Cardiac and Cerebral Involvement in TMA
Conditions: Thrombotic Microangiopathy,;   Thrombotic Thrombocytopenic Purpura,
Intervention: Other: Biological and imaging investigations
24 Recruiting Safety and Efficacy Study of Romiplostim to Treat ITP in Pediatric Subjects
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenic Purpura;   Immune Thrombocytopenia
Interventions: Drug: romiplostim;   Drug: Placebo
25 Completed
Has Results
Safety and Efficacy Study of Romiplostim (AMG 531) to Treat ITP in Pediatric Subjects
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP);   Thrombocytopenia in Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Interventions: Drug: Placebo;   Drug: AMG 531
26 Completed Vaccine Response After Rituximab for Chronic, Severe Idiopathic Thrombocytopenic Purpura
Conditions: Idiopathic Thrombocytopenic Purpura;   Immune Thrombocytopenic Purpura
Intervention: Biological: Inactivated Trivalent Influenza vaccine
27 Terminated Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy
Conditions: Thrombotic Microangiopathy;   Thrombotic Thrombocytopenic Purpura
Interventions: Drug: ARC 1779 Placebo;   Drug: ARC1779 Injection
28 Completed
Has Results
An Open Label Study of Romiplostim in Adult Thrombocytopenic Subjects With ITP
Conditions: Idiopathic Thrombocytopenic Purpura;   Thrombocytopenia;   Thrombocytopenic Purpura
Intervention: Biological: Romiplostim
29 Completed Clinical Trial of Rituximab in Children and Adolescents With Chronic Idiopathic Thrombocytopenic Purpura (ITP)
Conditions: Idiopathic Thrombocytopenic Purpura (ITP);   Immune Thrombocytopenic Purpura (ITP)
Intervention: Drug: rituximab
30 Not yet recruiting MONICA-SC: A Study to Evaluate the Efficacy, Safety and Tolerability of Blisibimod (A-623) Administration in Subjects With ITP
Conditions: Immune Thrombocytopenic Purpura;   Idiopathic Thrombocytopenic Purpura
Interventions: Biological: Blisibimod;   Other: Placebo
31 Completed Pilot Study of Rituximab for the Treatment of Acute Immune Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Rituximab;   Drug: Placebo
32 Completed
Has Results
Pilot Study of be Fostamatinib Disodium/R935788 for the Treatment of Adult Refractory Immune Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: Fostamatinib Disodium / R935788
33 Recruiting A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Interventions: Drug: Eltrombopag Tablets;   Drug: Eltrombopag PfOS
34 Active, not recruiting A Longitudinal 2-year Bone Marrow Study of Eltrombopag in Previously Treated Adults, With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: Eltrombopag olamine
35 Completed Subject Variability in Two Lots of E5501 Administered to Fed and Fasted Healthy Subjects
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Acute Idiopathic Thrombocytopenic Purpura;   Chronic Thrombocytopenia
Interventions: Drug: E5501 40 mg 2 x 20-mg tablets, orally, fasted;   Drug: E5501 40 mg 2 x 20-mg tablets, orally, with food;   Drug: E5501 40mg 2 x 20-mg tablets, orally, fasted
36 Withdrawn Prophylactic Plasma Infusion Therapy for Congenital Thrombotic Thrombocytopenic Purpura
Condition: Purpura, Thrombotic Thrombocytopenic
Interventions: Drug: Octaplas infusion and placebo (group 1);   Drug: Octaplas infusion and placebo (group 2)
37 Recruiting Multiple Rising Does Study (Subcutaneous Doses) of BI 655064 in Male and Female Patients With Chronic Primary Immune Thrombocytopenic Purpura (ITP).
Condition: Purpura, Thrombocytopenic, Idiopathic
Intervention: Drug: BI 655064
38 Completed
Has Results
Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT)
Condition: Purpura, Thrombocytopaenic, Idiopathic
Intervention: Drug: eltrombopag
39 Completed Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients
Conditions: Immune Thrombocytopenic Purpura;   Helicobacter Pylori Infection
Intervention: Drug: H. pylori triple therapy
40 Completed Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)
Condition: Thrombocytopenic Purpura
Intervention: Drug: AMG 531

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years